Mr. Terry Booth reports

AURORA PURCHASES 10,800 SHARES OF CANNIMED THERAPEUTICS INC.

Aurora Cannabis Inc. has purchased 10,800 common shares of CanniMed Therapeutics Inc.

The purchases were made in connection with Aurora's previously announced offer to purchase all of the common shares of CanniMed. Aurora announced its intention to purchase common shares of CanniMed in its offer to purchase and takeover bid circular dated Nov. 24, 2017, which is filed on SEDAR under CanniMed's SEDAR profile. CanniMed implemented a shareholder rights plan on Nov. 28, 2017, which prevented Aurora from commencing purchases in a timely fashion. The Ontario Securities Commission and the Saskatchewan Financial and Consumer Affairs Authority, in joint decisions dated Dec. 22, 2017, and issued on Dec. 27, 2017, cease traded the CanniMed rights plan.

The purchases were made by Aurora in the normal course through the facilities of the Toronto Stock Exchange.

Name of the purchaser:  Aurora Cannabis

Number of CanniMed shares purchased on Jan. 15, 2018:  10,800

Highest price paid for the CanniMed shares on Jan. 15, 2018:  $23.99

Aggregate number of CanniMed shares purchased through a published market since the commencement of the offer:  700,600

Average price paid for the CanniMed shares purchased through a published market since the commencement of the offer:  $23.0433

Total number of CanniMed shares held by Aurora after the purchase:  700,600

How to tender

Aurora encourages CanniMed shareholders to read the full details of the offer set forth in the takeover bid circular and accompanying offer documents, which contain detailed instructions on how CanniMed shareholders can tender their CanniMed common shares to the offer. For assistance in depositing CanniMed common shares to the offer, CanniMed shareholders should contact the depositary and the information agent for the offer, Laurel Hill Advisory Group, by phone at 1-877-452-7184 (North American toll-free phone) and 1-416-304-0211 (outside North America); facsimile at 416-646-2415; and e-mail at assistance@laurelhill.com.

About the offer

On Nov. 24, 2017, Aurora formally commenced its offer to purchase all of the issued and outstanding common shares of CanniMed for consideration consisting of common shares of Aurora. The offer document, including the takeover bid circular and related documents, are available on SEDAR.

The offer documents are also available on Aurora's website.

About Aurora Cannabis Inc.

Aurora's wholly owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR). The company operates a 55,200-square-foot, state-of-the-art production facility in Mountain View county, Alberta, known as Aurora Mountain, a second 40,000-square-foot, high-technology production facility known as Aurora Vie in Pointe-Claire, Que., on Montreal's West Island, and is currently constructing an 800,000-square-foot production facility, known as Aurora Sky, at the Edmonton International Airport, as well as is completing a fourth facility in Lachute, Que., through its wholly owned subsidiary, Aurora Larssen Projects Ltd.

We seek Safe Harbor.